The National One Week Prevalence Audit of Universal Meticillin-Resistant Staphylococcus aureus (MRSA) Admission Screening 2012

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Fuller, Christopher ^a   Robotham, Julie ^b   Savage, Joanne ^a   Hopkins, Susan ^b,c   Deeny, Sarah R ^b   Stone, Sheldon ^a,c   Cookson, Barry ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; HEALTH CARE POLICY; HEALTH CARE PRACTICE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INFECTION RATE; LABORATORY TEST; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PATIENT ASSESSMENT; PATIENT CARE; PATIENT IDENTIFICATION; POLYMERASE CHAIN REACTION; RISK FACTOR; SCREENING TEST;

CARRIER STATE; HUMANS; INFECTION CONTROL; MASS SCREENING; MEDICAL AUDIT; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PATIENT ADMISSION; PREVALENCE; QUESTIONNAIRES; STAPHYLOCOCCAL INFECTIONS;

EID: 84884188681     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074219     Document Type: Article

References (33)

1. HPA (2004) Staphylococcus aureus bacteraemia: England, Wales, and Northern Ireland: October to December 2003. CDR Wkly Volume 14No 12; (18 March 2004). Retrieved onpublished at whilst December year 1111 from http://www.hpa.org.uk/CDR/archives/archive04/news04_1.htm. HPA website, Last Accessed, 23rd August (2013).
2. Coia J, Duckworth G, Edwards D, Farrington C, Fry H, et al. (2006) Guidelines for control and prevention of MRSA. J Hosp Infect 63S: S1-S44.
3. Department of Health (2006) Code of practice for the prevention and control of healthcare associated infections. London: Department of Health. Retrieved onpublished at whilst December year 1111 from http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_081927 (Monitor website, last accessed 23rd August 2013).
4. NPSA (2004) Ready, Steady, Go. The full guide to implementing the cleanyourhands campaign in your Trust. Retrieved onpublished at whilst December year 1111 from http://www.npsa.nhs.uk/EasySiteWeb/GatewayLink.aspx?alId=5923. NPSA website, Last Accessed, April 16th (2013).
5. Department of Health (2005) Saving Lives: a delivery programme to reduce health care associated infection (HCAI) including MRSA. Retrieved onpublished at whilst December year 1111 from http://www.clean-safe-care.nhs.uk. Website: the National Archives. Accessed April 16th 2013.
6. Stone SP, Fuller C, Savage J, McAteer J, Besser S, et al. (2012) Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study. BMJ 344: e3005. doi:10.1136/bmj.e3005. PubMed: 22556101.
7. Kessel AS, Sharland M, (2013) The new UK antimicrobial resistance strategy and action plan. BMJ 346: f1601. doi:10.1136/bmj.f1601. PubMed: 23479662.
8. Department of Health (2010) The Operating framework for 2011/12 for the NHS in England. Retrieved onpublished at whilst December year 1111 from http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_122738 (Department of Health website, last accessed 16-04-2013).
9. Cooper BS, Stone SP, Kibbler CC, Cookson BD, Roberts JA, et al. (2004) Systematic review of the literature on isoaltion policies in the hospital management of MRSA. BMJ 329: 533-538. doi:10.1136/bmj.329.7465.533. PubMed: 15345626.
10. Cooper BS, Stone SP, Kibbler CC, Cookson BD, Roberts JA, et al. (2003) Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling. Health Technol Assess 7(39):: 1-194. PubMed: 14636487.
11. Department of Health (2008) Impact assessment of screening elective patients for MRSA. in Fuller C, Robothan J, Savage J, Deeny S, Hopkins Set al (2012)The NOW Prevalence Audit of MRSA Screening: final report p150 http://idrn.org/documents/resources/Final%20report.pdf (IDRN website: last accessed 27th August 2013).
12. Rao GP, Michalczyk P, Nayeem N, Walker G, Wigmore L, et al. (2007) Prevalence and risk factors for meticillin-resistant Staphylococcus aureus in adult emergency admissions - a case for screening all patients? J Hosp Infect 66: 15-21. doi:10.1016/j.jhin.2007.01.013. PubMed: 17376560.
13. Hardy K, Price C, Szczepura A, Gossain S, Davies R, et al. (2009) Reduction in the rate of methicillin-resistant Staphylococcus aureus acquisition in surgical wards by rapid screening for colonization: a prospective, cross-over study. Clin Microbiol Infect 16: 333-339. PubMed: 19622077.
14. Jeyaratnam D, Whitty CJ, Phillips K, Liu D, Orezzi C, et al. (2008) Impact of rapid screening tests on acquisition of methicillin resistant Staphylococcus aureus: cluster randomised crossover trial. BMJ: 336: 927-930. doi:10.1136/bmj.39525.579063.BE. PubMed: 18417521.
15. Creamer E, Dolan A, Sherlock O, Thomas T, Walsh J, et al. (2010) The Effect of Rapid Screening for Methicillin-Resistant Staphylococcus aureus (MRSA) on the Identification and Earlier Isolation of MRSA-Positive Patients. Infect Control Hosp Epidemiol 31: 374-381. doi:10.1086/651093. PubMed: 20184438.
16. Smyth ET, McIlvenny G, Enstone JE, (2008) Four Country Healthcare Associated Infection Prevalence Survey 2006: overview of the results. J Hosp Infect 69: 230-248. doi:10.1016/j.jhin.2008.04.020. PubMed: 18550218.
17. Cooper BS, Medley GF, Cookson B, Duckworth G, Kibbler C, et al. (2004) Methicillin-resistant Staphylococcus aureus in hospitals and the community: Stealth dynamics and control catastrophes. Proc Natl Acad Sci USA 101: 10223-10228. doi:10.1073/pnas.0401324101. PubMed: 15220470.
18. Robotham JV, Graves N, Barnett AG, Wilson J, Edgworth J, et al. (2011) Model-based evaluation and cost-effectiveness analysis of MRSA intervention policies. DH Report; [DH reference number PR-IP-0807-0410026].
19. Ritchie K, Bradbury I, Eastgate J, Foster L, Iqbal K, et al. (2007) The clinical and cost effectiveness of screening for meticillin-resistant Staphylococcus aureus (MRSA) Glasgow: Quality Improvement Scotland (NHS QIS). Health Technol Assess Rep 9.
20. National Audit Office (2009) Report by the comptroller and auditor general HC 560 session 2008-9 12 June 2009. Reducing Healthcare Associated Infections in Hospitals in England. London: HMSO. Retrieved onpublished at whilst December year 1111 from http://www.nao.org.uk/publications/0809/reducing_healthcare_associated.aSpx (National Audit Office website, last accessed April 16 2013).
21. Public accounts Committee (2009) Reducing healthcare associated infections in hospitals in England. Fifty-second report of session 2008-9. London: The Stationary Office. Retrieved onpublished at whilst December year 1111 from http://www.publications.parliament.uk/pa/cm/cmpubacc.htm (UK Parliament website, last accessed April 16 2013).
22. Hubben G, Bootsma M, Luteijn M, Glynn D, Bishai D, et al. (2011) Modelling the Costs and Effects of Selective and Universal Hospital Admission Screening for Methicillin-Resistant Staphylococcus aureus. PLOS ONE 6(3): e14783. Retrieved onpublished at whilst December year 1111 from http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0014783 (PLoS One website, last accessed 23rd August 2013) PubMed: 21483492.
23. Murthy A, De Angelis G, Pittet D, Schrenzel J, Uckay I, et al. (2010) Cost-effectiveness of universal screening on admission to surgery. Clin Microbiol Infect 16: 1747-1753. doi:10.1111/j.1469-0691.2010.03220.x. PubMed: 20331684.
24. Lee BY, Tsui Y, Bailey RR, Smith KJ, Muder RR, et al. (2009) Should Vascular Surgery Patients be screened pre-operatively for Methicillin-Resistant Staphylococcus aureus? Infect Control Hosp Epidemiol 30: 1158-1165. doi:10.1086/648087. PubMed: 19852665.
25. Harbarth S, Fankhauser C, Schrenzel J, Christenson J, Gervaz P, et al. (2008) Universal Screening for Methicillin-Resistant Staphylococcus aureus at Hospital Admission and Nosocomial Infection in Surgical Patients. JAMA 299: 1149-1157. doi:10.1001/jama.299.10.1149. PubMed: 18334690.
26. Leonhardt KL, Yakusheva O, Phelan D, Reeths A, Hosterman T, et al. (2011) Clinical Effectiveness and Cost Benefit of Universal versus Targeted Methicillin-Resistant Staphylococcus aureus Screening upon Admission in Hospitals. Infect Control Hosp Epidemiol 32: 797-803. doi:10.1086/660875. PubMed: 21768764.
27. Kjonegaard R, Fields W, Peddecord KM, (2013) Universal rapid screening for methicillin-resistant Staphylococcus aureus in the intensive care units in a large community hospital. Am J Infect Control 41: 45-50. doi:10.1016/j.ajic.2013.03.294. PubMed: 22651895.
28. Health Scotland Protection, (2011a) National Services Scotland, NHS Scotland MRSA Screening Pathfinder Programme Final Report Volume 1: An investigation of the Clinical Effectiveness of MRSA Screening, Health Protection Scotland [Report].
29. Health Scotland Protection, (2011b) NHS Scotland MRSA Screening Pathfinder Programme. Final report volume 2: An assessment of the Economics, Implementation and Modelling of Universal MRSA Screening. Health Protection Scotland [Report].
30. Health Scotland Protection, (2011c) National Services Scotland, Final Report Volume 3: Staff Patient Acceptability, Health Protection Scotland [Report].
31. Health Scotland Protection, (2011d) National Services Scotland, Final Report Volume 4: To Evaluate the Feasibility and Potential for Rollout of the MRSA Screening Programme 2011, Health Protection Scotland [Report].
32. Health Protection Agency (2012) Quarterly Epidemiological Commentary: Mandatory MRSA bacteraemia, Clostridium difficile infection & MSSA bacteraemia (up to April-June 2012). http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb_C/1259151891722 (Health Protection Agency website last accessed 23rd August 2013).
33. Smith A, Christie P, Stari T, (2011) Health Protection Scotland, National Services Scotland. Scotland: NHS. MRSA Screening; The Value of Nasal Swabbing versus Full Body Screening or Clinical Risk Assessment to Detect MRSA Colonisation at Admission to Hospital. Health Protection Scotland [Report].